During the third and final day of the 32nd Alzheimer Europe, on 19 October 2022, a symposium on “Community matters: Developing Alzheimer’s clinical trials together” was organised by Roche, during which the company launched a new report on “Integrating the perspectives of people living with Alzheimer’s disease and their study partners into clinical trial development”. Alzheimer Europe is pleased to have collaborated on the development of this report, which you can download, here: https://www.rocheresources.co.uk/content/dam/hcp-portals/uk2/documents/alzheimers/Roche_AD_Integrating_the_perspectives_of_PLWA_and_their_study_partners_in_CT_development_report.pdf
